43 postdoc-in-distributed-systems-and-controls-"Multiple" Fellowship positions at University of Oxford
Sort by
Refine Your Search
-
About the role This is an exciting opportunity to join the team that have been working on the rapid clinical development of vaccines against COVID-19 and other important outbreak pathogens including
-
The role is for a Clinical Research Fellow to join an exciting project – DREaMED (Defining, Recognising and Escalating Maternal Early Deterioration): Decreasing inequality through improved outcomes
-
position, across undergraduate and taught postgraduate cohorts, with no requirement that the postholder will undertake research during their appointment. The purpose of post is specifically to provide a time
-
pension scheme. Affordable and sustainable commuting options, including a cycle loan scheme, discounted bus travel, and season ticket loans. Access to a vibrant community through our social, cultural, and
-
and adoption leave, plus 12 weeks of full-pay paternity/partner leave. A commitment to hybrid and flexible working to suit your lifestyle. An excellent contributory pension scheme. Affordable and
-
teaching-only position, across undergraduate and taught postgraduate cohorts, with no requirement that the postholder will undertake research during their appointment. The purpose of post is specifically
-
. The purpose of post is specifically to provide a time-limited period of teaching development and support, so as a result there is no expectation that the post will be extended beyond the advertised period of
-
, “Conservativisms in an Age of Revolutions: The United States in an Atlantic World.” The post is funded for two years from 1 September 2025. This post is intended to provide a promising early career scholar with a
-
, international political economy, anthropology, sociology, human geography, economic history, media and communication studies, social policy or gender and sexuality studies. The postholder will lead the day-to-day
-
Fungal infections are a growing threat to planetary health and, in human medicine, the elderly and immunocompromised are a high-risk group. Resistance to the few existing treatments is increasingly